Epigral Limited share price

Epigral Limited manufactures and sells chlor-alkali and derivative products in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resin, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soap and detergents, fluoropolymers, paper and pulp, textiles, alumina, polyurethane foam, lithium, and polytetrafluoroethyle…Read more

Website NSE हिंदी में BSE

Basic MaterialsChemicalsNSE: EPIGRALISIN INE071N01016

16 Oct 2026, 3:29 PM IST₹995.80▲ 21.40 (2.20%)

Market Cap₹ 4,296 Cr.
Current Price₹ 995.80
High / Low₹ 1,730 / 807
Stock P/E15.9
Book Value₹ 515
Dividend Yield0.51 %
ROCE13.9 %
ROE16.10 %
Face Value₹ 10.0

More figures (10)

EPS (TTM)₹ 62.69
Price / Book1.93
OPM16.0 %
Debt / Equity0.26
Sales growth (3Y)4.9 %
Profit growth (3Y)-2.1 %
Promoter holding68.9 %
EV / EBITDA8.4
Beta0.31
All-time high₹ 2,407

Price chart

Price on NSE 50 DMA 200 DMA Volume

Returns	1M	3M	6M	YTD	1Y	3Y CAGR	5Y CAGR
EPIGRAL	-8.14%	-6.71%	-17.60%	-18.38%	-41.50%	+0.75%	+1.82%
Nifty 50	-0.31%	-3.85%	-4.34%	-11.42%	-9.53%	+5.46%	+4.76%

Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.

Quick take

Epigral Limited is in the Chemicals industry (Basic Materials), with a market value of ₹4,296 crore.
It trades at 15.9 times its last 12 months' earnings and 1.9 times book value.
Revenue grew 4.9% a year over the last 3 years, profit -2.1% a year.
Return on equity was 16.1% and return on capital employed 13.9% in the latest year.
Debt was 0.26 times shareholders' equity.
The share price is 42.4% below its 52-week high and down 41.5% over one year.
Promoters and insiders hold about 68.9%; institutions about 6.2%.

Pros

Strong return on equity: 18.5% on average over the last 3 years.
Borrowings are moderate at 0.26 times shareholders' equity.
Institutional (FII + DII) holding has risen by 4.7 points over 3 years.

Cons

Sales growth has been slow: 4.9% a year over the last 3 years.
Profit growth has been weak: -2.1% a year over the last 3 years.
Latest quarter (Jun 2026): profit fell 38% from a year ago.
Promoter holding has fallen by 2.55 points over 3 years, to 68.83%.

Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.

AI analysis

Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.

About Epigral Limited

Employees: 1,135
Head office: Ahmedabad

Basic MaterialsChemicals

S.No.	Company	CMP ₹	P/E	Mar Cap ₹ Cr	Div Yld %	NP Qtr ₹ Cr	Qtr Profit Var %	Sales Qtr ₹ Cr	Qtr Sales Var %	ROCE %	ROE %	P/B	OPM %	Debt / Eq	Prom. Hold. %	Sales ₹ Cr	Sales Var 3Yrs %
1.	Epigral	995.80	15.9	4,296	0.51	100	-37.93	705	16.29	13.9	16.1	1.93	16.0	0.26	68.86	2,527	4.9
2.	Navin Fluorine International	8,167.00	53.0	41,903	0.18	243	156.22	1,045	49.10	18.7	20.1	10.53	28.6	0.32	28.59	3,262	16.5
3.	Deepak Nitrite	1,598.50	27.8	21,802	0.47	345	207.50	2,578	36.39	10.8	9.8	3.74	9.8	0.28	49.85	7,761	-0.5
4.	Deepak Fertilisers And Petrochemicals Corporation	1,344.10	17.2	16,985	0.76	490	76.76	3,256	22.08	11.2	11.3	2.48	13.6	0.83	47.09	9,400	2.6
5.	Tata Chemicals	633.15	—	16,130	1.75	-17	—	4,255	21.26	-3.0	-8.9	0.76	4.2	0.38	38.71	14,397	-4.8
6.	Gujarat Narmada Valley Fertilizers & Chemicals	564.20	8.0	8,290	3.67	312	275.90	2,238	39.79	10.4	9.1	0.91	8.3	0.00	43.47	7,731	-8.8
7.	Archean Chemical Industries	478.60	60.7	5,909	0.53	31	-23.67	327	11.92	7.7	5.6	3.05	13.6	0.24	53.43	1,077	-9.2
8.	Ellenbarrie Industrial Gases	339.05	39.6	4,778	0.00	35	86.84	99	18.04	13.0	14.2	4.89	25.6	0.19	77.76	342	16.9
9.	Gujarat Alkalies and Chemicals	585.10	64.7	4,297	3.00	55	—	1,245	12.65	1.3	0.0	0.83	0.6	0.16	79.29	4,246	-1.2
10.	I G Petrochemicals	573.65	21.6	1,767	0.86	66	—	618	31.43	3.1	0.2	1.33	3.6	0.27	73.49	1,925	-6.5
	Median: 18 Co.	609.13	19.8	3,031	0.52	83	86.84	1,145	21.67	10.6	10.3	1.74	9.1	0.27	51.64	3,754	-0.9

Companies in the same industry; the median covers every company in it that we hold figures for. Tap a heading to sort. Sorting and comparing are ways to explore data, not recommendations.

Quarterly Results

Consolidated figures in ₹ crore /

₹ Cr	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	455	478	472	525	651	626	645	628	607	587	597	736	705
YOY Sales Growth %		-13.93%	-12.33%	-6.68%	43.15%	30.93%	36.84%	19.63%	-6.86%	-6.18%	-7.46%	17.29%	16.29%
	360	370	349	369	475	448	463	454	443	455	494	568	526
Material Cost %	60%	57%	53%	51%	55%	53%	52%	52%	53%	56%	60%	58%	56%
Employee Cost %	5%	4%	5%	5%	4%	4%	5%	5%	5%	5%	5%	5%	5%
Other Expenses %	14%	16%	17%	15%	14%	14%	16%	15%	16%	16%	18%	14%	14%
Operating Profit	95	108	123	155	176	178	183	173	163	132	103	169	179
OPM %	21%	23%	26%	30%	27%	29%	28%	28%	27%	23%	17%	23%	25%
Other Income	2	1	2	2	2	6	4	3	8	2	6	-1	4
Interest	18	21	20	14	14	27	-0	12	23	22	11	16	7
Depreciation	31	32	31	30	33	32	33	34	42	42	43	42	43
Profit before tax	48	56	74	113	131	124	154	131	107	70	55	111	133
	33%	32%	34%	32%	34%	35%	33%	34%	-50%	26%	28%	26%	26%
Current tax	9	10	14	20	23	22	38	15	25	18	14	28	35
Deferred tax	7	8	11	16	22	22	12	29	-79	1	2	0	-1
	32	38	49	77	86	81	104	87	161	51	39	81	100
Profit from associates	-0	-0	-0	1	-0	1	0	0	0	-0	-0	-1	1
Profit to shareholders		38	49	77		81	104	87	161	51	39	81	100
YOY Profit Growth %		-58.51%	-36.42%	0.71%	172.54%	113.97%	111.13%	12.44%	87.13%	-37.00%	-62.26%	-6.84%	-37.93%
EPS in Rs	7.58	9.14	11.81	18.60	20.67	19.57	24.25	20.14	37.25	11.87	9.07	18.76	23.12
Raw filing

₹ Cr	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	455	478	472	525	651	626	645	628	607	587	597	736	705
YOY Sales Growth %		-13.93%	-12.33%	-6.68%	43.15%	30.93%	36.84%	19.63%	-6.86%	-6.18%	-7.46%	17.29%	16.29%
	360	370	349	369	475	448	463	454	443	455	494	568	526
Material Cost %	60%	57%	53%	51%	55%	53%	52%	52%	53%	56%	60%	58%	56%
Employee Cost %	5%	4%	5%	5%	4%	4%	5%	5%	5%	5%	5%	5%	5%
Other Expenses %	14%	16%	17%	15%	14%	14%	16%	15%	16%	16%	18%	14%	14%
Operating Profit	95	108	123	155	176	178	183	173	163	132	103	169	179
OPM %	21%	23%	26%	30%	27%	29%	28%	28%	27%	23%	17%	23%	25%
Other Income	2	1	2	2	2	6	4	3	8	2	6	-1	4
Interest	18	21	20	14	14	27	-0	12	23	22	11	16	7
Depreciation	31	32	31	30	33	32	33	34	42	42	43	42	43
Profit before tax	48	56	74	113	131	124	154	131	107	70	55	111	133
	33%	32%	34%	32%	34%	35%	33%	34%	-50%	26%	28%	26%	26%
Current tax	9	10	14	20	23	22	38	15	25	18	14	28	35
Deferred tax	7	8	11	16	22	22	12	29	-79	1	2	0	-1
	32	38	49	77	86	81	104	87	160	52	39	82	99
YOY Profit Growth %		-58.36%	-36.12%	-0.17%	171.52%	111.18%	109.98%	12.98%	86.50%	-36.02%	-62.19%	-5.41%	-38.17%
EPS in Rs	7.62	9.18	11.87	18.45	20.70	19.38	24.23	20.08	37.18	11.94	9.07	18.99	22.99
Raw filing

Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Latest quarter on the right.

Profit & Loss

Consolidated figures in ₹ crore /

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	1,551	2,188	1,929	2,550	2,527	2,626
YOY Sales Growth %		41.10%	-11.84%	32.19%	-0.90%
	1,041	1,499	1,448	1,839	1,960	2,043
Material Cost %	49%	51%	55%	53%	57%	57%
Employee Cost %	5%	4%	5%	4%	5%	5%
Other Expenses %	13%	14%	15%	15%	16%	15%
Operating Profit	509	689	481	711	567	583
OPM %	33%	31%	25%	28%	22%	22%
Other Income	4	8	7	15	15	11
Interest	44	66	73	53	72	56
Depreciation	86	109	124	133	168	170
Profit before tax	383	522	291	540	342	368
	34%	32%	33%	34%	3%	26%
Current tax	70	94	53	98	85
Deferred tax	61	75	42	85	-76
	253	353	196	358	332	271
Profit from associates		-0	0	1	-1	-1
Profit to shareholders		353	196	358	332	271
YOY Profit Growth %		39.76%	-44.57%	82.67%	-7.19%
EPS in Rs	60.84	85.03	47.13	84.68	76.95	62.82
Dividend Payout %		7%	13%	12%	6%

Compounded Sales Growth

3 Years:: 5%
TTM:: 5%

Compounded Profit Growth

3 Years:: -2%
TTM:: -37%

Stock Price CAGR

5 Years:: 2%
3 Years:: 1%
1 Year:: -42%

Return on Equity

4 Years:: 22%
Last Year:: 16%

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	1,551	2,188	1,929	2,550	2,527	2,626
YOY Sales Growth %		41.10%	-11.84%	32.19%	-0.90%
	1,041	1,499	1,448	1,839	1,960	2,043
Material Cost %	49%	51%	55%	53%	57%	57%
Employee Cost %	5%	4%	5%	4%	5%	5%
Other Expenses %	13%	14%	15%	15%	16%	15%
Operating Profit	509	689	481	711	567	583
OPM %	33%	31%	25%	28%	22%	22%
Other Income	4	8	7	15	15	11
Interest	44	66	73	53	72	56
Depreciation	86	109	124	133	168	170
Profit before tax	383	523	291	540	342	368
	34%	32%	33%	34%	3%	26%
Current tax	70	94	53	98	85
Deferred tax	61	75	42	85	-76
	253	353	196	357	333	272
YOY Profit Growth %		39.78%	-44.59%	82.19%	-6.64%
EPS in Rs	60.84	85.04	47.12	84.45	77.19	62.99
Dividend Payout %		7%	13%	12%	6%

Compounded Sales Growth

3 Years:: 5%
TTM:: 5%

Compounded Profit Growth

3 Years:: -2%
TTM:: -37%

Stock Price CAGR

5 Years:: 2%
3 Years:: 1%
1 Year:: -42%

Return on Equity

4 Years:: 22%
Last Year:: 16%

Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.

Balance Sheet

Consolidated figures in ₹ crore, as at 31 March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	42	42	43	43
Reserves	1,028	1,213	1,861	2,178
	769	909	593	572
Long term borrowings	435	492	449	334
Short term borrowings	332	416	136	229
	594	631	655	712
Trade payables	110	184	186	260
Current liabilities	648	780	496	710
Total Liabilities	2,432	2,794	3,152	3,505
	1,952	2,235	2,311	2,567
Gross block	2,459	2,861	3,025	3,406
Accumulated depreciation	507	627	713	839
Goodwill & intangibles	25	22	19	16
CWIP	174	490	92	465
	306	70	749	473
Inventories	212	263	388	349
Trade receivables	166	179	232	417
Cash & equivalents	14	3	19	5
Current assets	419	502	775	827
Total Assets	2,432	2,794	3,152	3,505

Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.

Cash Flows

Consolidated figures in ₹ crore, financial years ending March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	626	398	441	436
Profit for the year	353	196	358	332
Working capital changes	41	-38	-167	-64
Direct taxes paid	-107	-51	-110	-73
	-437	-401	-262	-355
Fixed assets purchased	-416	-398	-195	-394
Fixed assets sold			8	9
Investments purchased	-0	-3	-309	-151
Investments sold			233	178
	-200	-8	-164	-94
Proceeds from borrowings	75	213	137	65
Repayment of borrowings	-139	-196	-420	-86
Interest paid	-60	-72	-66	-49
Dividends paid	-24	-25	-42	-18
Net Cash Flow	-11	-11	15	-14
Free Cash Flow	210	-1	246	41

Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.

Ratios

Ratio	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
ROE	—	33.0%	16.9%	22.6%	16.1%
ROCE	—	32.1%	17.5%	22.0%	13.9%
Operating margin	—	26.7%	18.9%	23.0%	16.0%
Net margin	—	16.3%	10.3%	14.2%	13.3%
Debt / equity	—	0.72	0.72	0.31	0.26
Current ratio	—	0.65	0.64	1.56	1.16
Debtor days	—	28	34	34	61
Inventory days	—	66	86	100	85
Days payable	—	34	60	48	63
Cash conversion cycle	—	60	60	86	83
Working capital days	—	-38	-54	41	17

Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; cash conversion cycle = debtor + inventory − payable days; working capital days = (current assets − current liabilities) ÷ sales × 365.

Shareholding Pattern

Numbers in percentages · as filed with NSE each quarter

Promoters 68.83%
FIIs 0.99%
DIIs 4.90%
Government 0.02%
Public 25.26%

%	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	71.38%	71.49%	71.58%	71.58%	68.94%	68.95%	68.83%	68.83%	68.83%	68.83%	68.83%	68.83%
	1.18%	1.36%	1.47%	2.09%	3.01%	3.01%	3.05%	2.71%	2.36%	1.54%	1.03%	0.99%
Foreign portfolio investors (Cat. I)	1.11%	1.23%	1.29%	1.64%	2.69%	2.77%	2.80%	2.57%	2.22%	1.41%	1.01%	0.87%
Foreign portfolio investors (Cat. II)	0.06%	0.13%	0.17%	0.46%	0.32%	0.24%	0.26%	0.14%	0.14%	0.13%	0.02%	0.12%
	0.05%	0.02%	0.18%	1.17%	4.31%	4.66%	4.79%	4.92%	5.13%	4.90%	5.56%	4.90%
Mutual funds	0.05%	0.02%	0.05%	1.04%	4.15%	4.48%	4.59%	4.74%	5.09%	4.90%	5.52%	4.87%
Alternative investment funds			0.13%	0.13%	0.16%	0.18%	0.19%	0.19%	0.04%		0.04%	0.02%
Government	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%
	27.36%	27.10%	26.74%	25.13%	23.72%	23.35%	23.31%	23.52%	23.66%	24.70%	24.55%	25.26%
Retail (up to ₹2 lakh)	16.25%	14.99%	14.82%	13.55%	12.62%	12.24%	12.28%	11.85%	11.93%	12.56%	12.43%	12.68%
HNIs (above ₹2 lakh)	4.94%	5.17%	5.00%	4.96%	4.75%	4.73%	4.68%	5.17%	5.23%	5.37%	5.45%	5.60%
NRIs	1.46%	1.40%	1.47%	1.44%	1.36%	1.32%	1.33%	1.35%	1.35%	1.48%	1.50%	1.52%
Bodies corporate	2.28%	3.00%	2.96%	2.84%	2.72%	2.78%	2.76%	2.80%	2.82%	2.87%	2.79%	3.01%
IEPF	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%
No. of Shareholders	92,959	88,870	85,761	83,176	81,697	80,878	79,951	78,605	77,562	77,583	76,305	76,384

Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.

Mutual funds & institutions holding Epigral

Holder (above 1%)	Stake
BANDHAN Small Cap FundMutual fund	3.38%
HSBC Value FundMutual fund	1.50%

As named in the shareholding pattern for Sep 2026 filed with NSE; mutual funds together hold 4.87% of the company. Shareholders below 1% are not named in the filing.

Documents

Announcements

All announcements on NSE →

Annual reports

Credit ratings

Concalls & investor meets

Filings made by the company with NSE; documents open on NSE's website.

Key dates

Ex-dividend date: 1 Jun 2026
Latest quarter: 30 Jun 2026
Financial year end: 31 Mar 2026

Trade with our broking desk

Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.

Open an account How it works

Latest news

In the news

Epigral EPIGRAL Reg 74(5) Certificate Q2 FY27 FiledKalkine India · 1 d ago

From the company (NSE)

Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.

Questions about Epigral Limited

What is the share price of Epigral Limited today?

Epigral Limited (EPIGRAL) last traded at ₹995.80 on NSE (16 Oct 2026, 3:29 PM IST). Prices may be delayed.

What is the market cap of Epigral Limited?

About ₹4,296 crore at the latest price.

What is the P/E ratio of Epigral Limited?

About 15.9 times its earnings over the last 12 months.

Is Epigral Limited a good investment?

We do not give views on individual shares. Whether any share suits you depends on your goals, time horizon and risk appetite; for long-term goals, a diversified mutual fund is often a simpler way to own shares. Investments in securities markets are subject to market risks.

How can I buy Epigral Limited shares?

You need a trading and demat account with a SEBI-registered stock broker. We can help you open one through Parshvanath Investments, an Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539). We provide execution and account service only, not tips or research.

Important. Prices from NSE via Yahoo Finance. Quarterly and annual results, shareholding and documents are taken from the filings the company made with NSE; balance sheet, cash flow and valuation figures are compiled by Yahoo Finance; ratios are computed by us from them. Figures may be delayed or revised. This page is for information only: it is not research, a recommendation or an offer to buy or sell any security. Investments in securities markets are subject to market risks; read all related documents carefully before investing. Plenitude Connect Private Limited is an AMFI-registered Mutual Fund Distributor (ARN-130934); share broking is offered through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539).

Talk to us

Have a question about this topic?

Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.

Get in touch

We typically respond within 2 hours on business days.

Call us

CA Amit Kumar Jain+91 93522 44475 Arihant Jain+91 80056 49698 Poornima Jain+91 92525 44475

Email ussupport@plenitude.co.in

WhatsAppChat with an expert

Visit us5C, Laxmi Colony, Near Bohra Ji Ka Bagh, Opp. Laxmi Mandir Cinema, Tonk Road, Jaipur, Rajasthan 302015

Mon–Sat · 10:00 AM – 7:00 PM IST

In your free consultation

A health check of your current investments
A goal-based plan for retirement, education or a home
Ways to save tax that fit your situation
Clear next steps, with zero pressure to invest

2,000+Investors

₹250 Cr+Client assets

15+ yrsExperience

AMFI Registered Mutual Fund Distributor · ARN-130934

Experts are available Mon–Sat, 10 AM – 7 PM

Book your free wealth consultation

100% free
No obligation
Reply within 2 hours

First name *

Last name *

Email *

Phone *

+91

I'm interested in *

Best day for a call

Preferred time

How can we help? (optional)

Upload your portfolio (optional, get a free expert review)Attach your portfolio statement · PDF, Excel or CSV (e.g. CAS), max 10 MB

I consent to being contacted by Plenitude Connect about financial services. My data will be handled as per the Privacy Policy.

Join 2,000+ investors who plan with Plenitude

Your details are private and never shared.

Epigral Limited share price

Price chart

Quick take

Pros

Cons

AI analysis

About Epigral Limited

Peer comparison

Quarterly Results

Profit & Loss

Projection — your assumptions

Related party transactions

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Mutual funds & institutions holding Epigral

Documents

Announcements

Annual reports

Credit ratings

Concalls & investor meets

Key dates

Trade with our broking desk

Latest news

In the news

From the company (NSE)

Questions about Epigral Limited

Have a question about this topic?

Book your free wealth consultation

Request received!

What happens next